| 000 | 01707 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516231502.0 | ||
| 264 | 0 | _c20151012 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1098-660X | ||
| 024 | 7 |
_a10.1128/JCM.02438-14 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStreicher, Elizabeth M | |
| 245 | 0 | 0 |
_aRapid sequencing of the Mycobacterium tuberculosis pncA gene for detection of pyrazinamide susceptibility. _h[electronic resource] |
| 260 |
_bJournal of clinical microbiology _cNov 2014 |
||
| 300 |
_a4056-7 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAmidohydrolases _xgenetics |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGenotyping Techniques _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 |
_aPyrazinamide _xpharmacology |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aSequence Analysis, DNA _xmethods |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aMaharaj, Kashmeel | |
| 700 | 1 | _aYork, Talita | |
| 700 | 1 | _aVan Heerden, Carel | |
| 700 | 1 | _aBarnard, Marinus | |
| 700 | 1 | _aDiacon, Andreas | |
| 700 | 1 | _aMendel, Carl M | |
| 700 | 1 | _aBosman, Marlein E | |
| 700 | 1 | _aHepple, Juli A | |
| 700 | 1 | _aPym, Alexander S | |
| 700 | 1 | _aWarren, Robin M | |
| 700 | 1 | _avan Helden, Paul D | |
| 773 | 0 |
_tJournal of clinical microbiology _gvol. 52 _gno. 11 _gp. 4056-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JCM.02438-14 _zAvailable from publisher's website |
| 999 |
_c24137735 _d24137735 |
||